Clinical Trials Sponsored by National Institute of Respiratory Diseases, Mexico

Total 6763 results

National Institute of Allergy and Infectious Diseases...

Completed

A Systems Biology Approach to Malaria Immunity

Plasmodium Falciparum Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Cytomegalovirus Infection

United Kingdom, United States
National Institute of Allergy and Infectious Diseases...

Completed

H1N1v Virus Challenge Study in Healthy Subjects

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children

Pneumonia

United States
National Institute of Allergy and Infectious Diseases...

Completed

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Minocycline Pharmacokinetics (ACUMIN)

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

Avian Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Avian Influenza | Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers

Helminthic Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

BCG Vaccination Delivered Intradermally, Orally and by Combined Routes

Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

YCFM (Youth Correctional Facilities Males)

Chlamydial Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

Influenza A Virus Infection | Swine Flu

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso

Plasmodium Falciparum Infection

Burkina Faso
National Institute of Allergy and Infectious Diseases...

Terminated

Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)

Coccidioidomycosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Blood and Plasma Collection For Use in Future Clinical Trials

Influenza A Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Respiratory Syncytial Virus Infection | Antiviral Prophylaxis

United States
National Institute of Allergy and Infectious Diseases...

Completed

T-cell Response-Flu Risk in Older Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Papua New Guinean Duffy Negativity And Vivax Malar

Plasmodium Vivax Malaria

Papua New Guinea
National Institute of Allergy and Infectious Diseases...

Completed

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications (IRC003)

Influenza

United States, Australia, Argentina, Mexico, Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Funguria in Hospitalized Patients

Candidiasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Malaria Prevalence in Children

Plasmodium Falciparum Malaria

Gambia
National Institute of Allergy and Infectious Diseases...

Completed

A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051

Corona Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Plasmodium Resistance in A. Gambiae

Malaria | Plasmodium Falciparum Malaria

Burkina Faso
National Institute of Allergy and Infectious Diseases...

Completed

Immunity to Human Cholera in Bangladesh

Cholera

Bangladesh
National Institute of Allergy and Infectious Diseases...

Terminated

Zinc and Pneumonia Protocol

Respiratory Infections, Acute

Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

Phase 1 Trial of Inactivated West Nile Virus Vaccine

West Nile Viral Infection

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Development in Pediatric Transplantation (IMPACT)

End Stage Renal Disease | Chronic Kidney Failure

United States
National Institute of Allergy and Infectious Diseases...

Completed

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand

Dengue

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Tuberculosis Treatment Shortening Trial

Tuberculosis

Brazil, Philippines, Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Tuberculosis

United States, Brazil
National Institute of Allergy and Infectious Diseases...

Withdrawn

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Influenza
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Influenza A Virus, H7N9 Subtype

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers

Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus

Influenza, Human

United States
National Institute of Allergy and Infectious Diseases...

Completed

Cefixime / Azithromycin pK Study

Gonorrhoea

United States
National Institute of Allergy and Infectious Diseases...

Completed

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Antiviral DAS-181-F04 in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Sclerosis | Scleroderma, Systemic

United States
National Institute of Allergy and Infectious Diseases...

Completed

Live Lung Donor Cross-sectional Cohort Study

Lung Transplantation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

Gonorrhoea

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

West Nile Virus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Hemorrhagic Fever, Ebola

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

Atopic Dermatitis

United States

Clinical Trials Sponsored by National Institute of Respiratory Diseases, Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations